Sarepta Therapeutics Inc.
02/25/2026 | Press release | Distributed by Public on 02/25/2026 16:10
Management Change/Compensation (Form 8-K)
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 25, 2026, Douglas Ingram notified Sarepta Therapeutics, Inc. (the "Company") of his decision to retire as Chief Executive Officer by the end of 2026 or upon the appointment of his replacement. The Company has commenced a search of internal and external candidates for Mr. Ingram's replacement.
Sarepta Therapeutics Inc. published this content on February 25, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 25, 2026 at 22:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]